NCT05098717

Brief Summary

Patients with pulmonary fibrosis and associated usual interstitial pneumonia that require mechanical ventilation for acute respiratory failure experience poor clinical outcomes. This may be influenced by the unfavorable interaction between the fibrotic lung and the stress and strain stimuli generated during controlled ventilation. Although there is no consensus on how to ventilate these patients, much of the recommendations followed in clinical practice are taken from the experience on patients with acute respiratory distress syndrome. Among these, measuring the esophageal pressures and adjusting positive-end expiatory pressure to make trans-pulmonary pressures positive can decrease atelectasis, derecruitment of lung, and cyclical opening and closing of airways and alveoli, thus optimizing lung mechanics and oxygenation. The effect of this strategy on the fibrotic lung has not yet been documented. With this observational study we aim at documenting the effect of PEEP titration maneuver based on end-expiratory trans-pulmonary pressure on lung mechanics of patients with pulmonary fibrosis and UIP pattern,

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Feb 2023Jan 2027

First Submitted

Initial submission to the registry

October 15, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 28, 2021

Completed
1.3 years until next milestone

Study Start

First participant enrolled

February 8, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

2.9 years

First QC Date

October 15, 2021

Last Update Submit

April 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lung elastance

    The effect of PEEP titration according to end-expiratory transpulmonary pressure on lung elastance will be analyzed.

    2 hours.

Secondary Outcomes (1)

  • P/F ratio

    2 hours

Study Arms (2)

UIP patients

Patients with pulmonary fibrosis and UIP pattern undergoing mechanical ventilation for acute respiratory failure

ARDS patients

Patients with ARDS undergoing mechanical ventilation for acute respiratory failure

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with lung fibrosis and UIP pattern undergoing esophageal manometry and controlled mechanical ventilation for acute respiratory failure admitted to the Intensive Care Unit and Respiratory Intensive Care Unit of the University Hospital of Modena that will fulfill the eligibility criteria will be enrolled.

You may qualify if:

  • pulmonary fibrosis with UIP pattern
  • subjected to endotracheal intubation and controlled mechanical ventilation for acute respiratory failure
  • candidate to a trial of PEEP titration according to positive end expiratory pressure.

You may not qualify if:

  • chest wall deformities
  • chronic obstructive pulmonary disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliero Universitaria Policlinico di Modena

Modena, Italy

RECRUITING

MeSH Terms

Conditions

Idiopathic Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Pulmonary FibrosisLung Diseases, InterstitialLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 15, 2021

First Posted

October 28, 2021

Study Start

February 8, 2023

Primary Completion

January 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

April 25, 2025

Record last verified: 2025-04

Locations